Over a quarter ago |
Downgrade
|
Baird downgraded… Baird downgraded Stericycle to Neutral from Outperform with a price target of $53, down from $65. The shares traded sharply lower after missing Q4 results, guiding 2023 well below expectations and significantly lowering long-term free cash flow views, the analyst tells investors in a research note. With free cash flow targets pushed out two years, the stock's risk/reward skews less favorably, says the firm. It still sees significant fundamental improvement potential for Stericycle, but says the removal of the expected "hockey stick" margin and free cash flow expansion "diminishes the near-term upside." ShowHide Related Items >><< - 12/01/22
- Carenet Health acquires Stericycle Communication Solutions
- 08/08/22 RBC Capital
- Stericycle price target lowered to $70 from $82 at RBC Capital
- 05/12/22 Berenberg
- Stericycle downgraded on inflationary environment at Berenberg
- 05/12/22 Berenberg
- Stericycle downgraded to Hold from Buy at Berenberg
- 04/29/22 Baird
- Stericycle price target lowered to $63 from $72 at Baird
- 02/23/23
- Stericycle reports Q4 adjusted EPS 60c, consensus 60c
- 11/03/22
- Stericycle reports Q3 adjusted EPS 65c, consensus 58c
|
Earnings
|
Reports Q4 revenue… Reports Q4 revenue $670.4M, consensus $697.18M. "Our fourth quarter performance was in line with our expectations," said Cindy Miller, President and Chief Executive Officer. "With strong second half execution, we made important progress across our key business priorities during a challenging operating year." ShowHide Related Items >><< - 12/01/22
- Carenet Health acquires Stericycle Communication Solutions
- 08/08/22 RBC Capital
- Stericycle price target lowered to $70 from $82 at RBC Capital
- 05/12/22 Berenberg
- Stericycle downgraded on inflationary environment at Berenberg
- 05/12/22 Berenberg
- Stericycle downgraded to Hold from Buy at Berenberg
- 04/29/22 Baird
- Stericycle price target lowered to $63 from $72 at Baird
- 11/03/22
- Stericycle reports Q3 adjusted EPS 65c, consensus 58c
|
Hot Stocks
|
Carenet Health announced… Carenet Health announced it has acquired Stericycle Communication Solutions, an industry player in patient engagement technology and solutions and a service of Stericycle. "At this critical moment in healthcare, where health systems are working hard to get patients back in the door for needed procedures, we're pleased to be able to provide 24/7 modernized and elevated technology tools with the overall goals of better access, better experiences, better outcomes, and better profitability," said John Erwin, Carenet chief executive officer. "Carenet is now the industry's most experienced and comprehensive healthcare consumer engagement company, delivering dynamic integrated solutions that support the ongoing shift to value-based care." ShowHide Related Items >><< - 08/08/22 RBC Capital
- Stericycle price target lowered to $70 from $82 at RBC Capital
- 05/12/22 Berenberg
- Stericycle downgraded on inflationary environment at Berenberg
- 05/12/22 Berenberg
- Stericycle downgraded to Hold from Buy at Berenberg
- 04/29/22 Baird
- Stericycle price target lowered to $63 from $72 at Baird
- 11/03/22
- Stericycle reports Q3 adjusted EPS 65c, consensus 58c
- 08/08/22
- Stericycle narrows FY22 EPS view to $2.00-$2.15 from $2.00-$2.30
- 08/05/22
- Stericycle reports Q2 adjusted EPS 48c vs 67c last year
- 08/08/22
- What You Missed On Wall Street On Monday
- 08/08/22
- What You Missed On Wall Street This Morning
|
Earnings
|
Reports Q3 revenue… Reports Q3 revenue $690.3M, consensus $675.21M. "Our third quarter results build upon the momentum we began to experience in the second quarter, as revenue, margin, adjusted earnings per share, and free cash flow all improved. We remain focused on executing on our five key business priorities and continuing this momentum through the rest of this year," said Cindy Miller, President and Chief Executive Officer. ShowHide Related Items >><< - 08/08/22 RBC Capital
- Stericycle price target lowered to $70 from $82 at RBC Capital
- 05/12/22 Berenberg
- Stericycle downgraded on inflationary environment at Berenberg
- 05/12/22 Berenberg
- Stericycle downgraded to Hold from Buy at Berenberg
- 04/29/22 Baird
- Stericycle price target lowered to $63 from $72 at Baird
- 08/08/22
- Stericycle narrows FY22 EPS view to $2.00-$2.15 from $2.00-$2.30
- 08/05/22
- Stericycle reports Q2 adjusted EPS 48c vs 67c last year
- 08/08/22
- What You Missed On Wall Street On Monday
- 08/08/22
- What You Missed On Wall Street This Morning
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 08/08/22
- W&T Offshore rises 18.5%
- 08/08/22
- W&T Offshore sees 2022 total equivalents 14,450-15,450 MBoe
- 08/08/22
- W&T Offshore sees Q3 total equivalents 3,550-4,050 MBoe
- 08/08/22
- W&T Offshore sees 2022 average daily equivalents 39.5-42 MBoe/d
- 08/05/22
- Western Digital drops 8% to $45.80 after Q1 guidance misses estimates
- 07/21/22
- Western Digital, Micron trade lower after Seagate earnings miss
- 07/21/22
- Seagate drops 11% to $74.05 after results miss estimates
- 06/08/22
- Western Digital jumps 3.7% after announcing review to split Flash and HDD units
WBD Warner Bros. Discovery - 08/04/22
- Warner Bros. Discovery backs long-term leverage target of 2.5-3.0
- 08/04/22
- Warner Bros. Discovery sees FY23 adjusted EBITDA of 'at least $12B'
- 08/04/22
- AT&T, Warner Bros. Discovery announces distribution pact for HBO Max
- 08/04/22
- Warner Bros. Discovery launches dedicated CNN Originals hub on discovery+
- 08/07/22
- Elon Musk challenges Twitter CEO to 'a public debate' on bots
- 08/07/22
- Musk says Twitter deal should not proceed if SEC filings 'materially false'
- 08/05/22
- Twitter rejects Elon Musk's claims that he was 'hoodwinked'
- 08/05/22
- Twitter Chairman says Musk's claims 'factually inaccurate'
- 08/08/22
- Tyson Foods: Demand for chicken 'extremely strong'
- 08/08/22
- Tyson: Prepared fods unit can't fulfill all orders due to supply constraints
- 08/08/22
- Tyson Foods CEO says demand 'relatively steady'
- 08/08/22
- Tyson Foods focused on overcoming supply chain challenges, says CEO
- 08/05/22
- Tesla confirms three-for-one stock split
- 08/03/22
- American Battery Metals appoints Belanger as Staff Analytical Chemist
- 05/23/22
- TPI Composites appoints Miller as CFO
- 05/19/22
- TPI Composites approves changes to corporate governance policies
- 02/25/22
- TPI Composites trading resumes
- 02/25/22
- TPI Composites trading halted, volatility trading pause
- 04/20/22
- Stericycle confirms anti-corruption resolutions with DOJ, SEC
- 04/20/22
- Stericycle charged by SEC with bribery schemes in Latin America
- 02/24/22
- Stericycle sees five-year CAGR of 3%-5%
- 05/16/22
- David Einhorn's Greenlight adds Southwestern, exits Sonos in Q1
- 05/11/22
- Sonos introduces Sonos Voice Control
- 04/11/22
- Sonos acquiures 'audio transducers' firm Mayht for $100M to enhance portfolio
- 03/30/22
- Sonos to replace Chart Industries in S&P 600 at open on 3/30
- $22.06 /
+2.195 (+11.05%) - 08/08/22
- Signify Health rises 14.5%
- 08/08/22
- Signify Health rises 15.9%
- 08/03/22
- Signify Health sees FY HCS revenue $800M-$810M
- 08/03/22
- Paramount+ to launch as a Premium Subscription within Roku Channel
- 07/28/22
- Roku drops 25% to $63.40 after Q2 results, Q3 guidance miss estimates
- 07/26/22
- Cathie Wood's ARK Investment bought 585K shares of Roku today
- 06/23/22
- Crackle launches updated app on Roku devices
RETA Reata Pharmaceuticals - $24.02 /
-11.895 (-33.12%) - 08/08/22
- Reata CEO looks forward to working with FDA on review of omaveloxone NDA
- 08/08/22
- Reata Pharmaceuticals trading resumes
- 08/08/22
- Reata Pharmaceuticals trading halted, volatility trading pause
- 05/26/22
- Reata Pharmaceuticals' NDA for omaveloxolone granted Priority Review by FDA
- 06/23/22
- uniQure provides update on low-dose cohort in Phase I/II trial of AMT-130
- 06/22/22
- uniQure announces grant equity awards to 32 new employees
- 05/24/22
- uniQure announces FDA accepts priority review BLA for etranacogene dezaparvovec
- 05/11/22
- uniQure announces inducement grants under Nasdaq listing rule 5635(c)(4)
- 08/08/22
- Palantir falls -12.0%
- 08/08/22
- Palantir falls -14.4%
- 08/08/22
- Palantir falls -12.2%
- 07/28/22
- Palantir announces $99.9M contract with U.S. Army Research Laboratory
- 08/08/22
- Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash
- 08/08/22
- Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash
- 08/07/22
- Myovant Sciences, Pfizer receive FDA approval of MYFEMBREE
- 08/05/22
- Fulcrum Therapeutics up 8% after WSJ says Pfizer in talks to buy Global Blood
- $177.97 /
-11.97 (-6.30%) - 08/08/22
- Nvidia falls 6.9% to $176.74 after negative Q2 revenue pre-announcement
- 07/20/22
- Motorsport Games brings two titles to NVIDIA GeForce NOWNvidia
- 07/15/22
- U.S. video game spending falls 11% y/y in June, says NPD
- 07/12/22
- Nvidia announces hybrid quantum-classical computing platform
- $241.52 /
+101.41 (+72.38%) - 08/08/22
- Zai Lab partner Karuna announces results from Phase 3 EMERGENT-2 trial
- 08/08/22
- Karuna Therapeutics says Phase 3 EMERGENT-2 trial met primary endpoint
- 07/28/22
- Google updates Play Store policies around intrusive advertisements
- 08/02/22
- Mandiant to not provide guidance due to pending transaction with Google
- 08/02/22
- Thryv and Google team to streamline communication for small businesses
- 07/31/22
- Fly Intel: Top five weekend stock stories
- 07/29/22
- Google says Stadia game streaming service not shutting down
- 08/05/22
- Global Blood Therapeutics trading resumes
- 07/28/22
- First Solar to supply 2.4 GW of PV solar modules to Intersect Power
- 07/26/22
- First Solar issues 2022 Sustainability Report
- 07/25/22
- First Solar announces Akuo placed order for 500MW of thin film PV solar modules
- 07/21/22
- First Solar to supply Solarvest Holdings with 93 MW for Malaysian projects
- 08/08/22
- Whirlpool confirms pact with Emerson Electric to acquire InSinkErator for $3B
- 08/08/22
- Emerson Electric to sell InSinkErator business to Whirlpool for $3B
- 08/08/22
- Emerson Electric to sell InSinkErator business to Whirlpool for $3B
- 07/27/22
- Emerson unit AspenTech to acquire Micromine, no terms
- 05/13/22
- Soros buys Lucid, exits GM in Q1
- 04/27/22
- Elanco secures exclusive U.S. license for Bovaer production
- 04/12/22
- Elanco unveils plans for global headquarters in Indianapolis
- 04/11/22
- Elanco, Ginkgo Bioworks launch BiomEdit, a microbiome innovation company
- 08/07/22
- Fly Intel: Top five weekend stock stories
- 08/04/22
- CDW appoints Carolyn Wiesenhahn as CPO
- 08/03/22
- CVS Health says liquidity, cash position 'remain excellent'
- 08/03/22
- CVS Health says posted strong results across all business segments in Q2
- $34.96 /
+11.46 (+48.77%) - 08/08/22
- CinCor Pharma announces data for Phase 2 BrigHtn trial evaluating baxdrostat
- 08/08/22
- CinCor Pharma announces upcoming milestones
- 07/26/22
- CinCor Pharma announces last patient randomized in Phase 2 HALO trial
- 06/01/22
- CinCor Pharma doses first patient in Phase 2 figHTN-CKD trial
- 08/08/22
- Carlyle Group CEO Kewsong Lee to step down, Bill Conway to be interim CEO
- 07/12/22
- Madison Dearborn Partners to acquire majority stake in Unison from Carlyle
- 05/16/22
- Carlyle to acquire ManTech for $96 per share in $4.2B enterprise value deal
- 05/09/22
- White Mountains to sell NSM Insurance Group to Carlyle Group
- 08/08/22
- BioNTech backs FY22 CapEx view EUR 450M- EUR 550M
- 08/05/22
- BioNTech, Genmab expand immunotherapies collaboration
- 07/27/22
- BioNTech, Pfizer to study enhanced COVID-19 mRNA-based vaccine candidate
- 07/19/22
- Pfizer, BioNTech complete submission to EMA for Omicron BA.1 adapted vaccine
- 08/03/22
- Italian Air Force extends Performance Based Logistics relationship with Boeing
- 08/01/22
- Boeing to open new BR&T center in Japan in cooperation with METI
- 07/28/22
- Boeing names Brian Besanceney as chief communications officer
- 08/05/22
- iRobot to be acquired by Amazon for $61/share in deal valued at $1.7B
- 08/05/22
- Amazon to acquire iRobot for $61.00 per share in cash
- 08/05/22
- iRobot to be acquired by Amazon for $61/share in deal valued at $1.7B
- 08/02/22
- Kaplan, Amazon partner for career, student support services
- 08/05/22 Susquehanna
- Susquehanna downgrades Twitter on 'uncertainty and disruption' from takeover
- 08/05/22 Susquehanna
- Twitter downgraded to Neutral from Positive at Susquehanna
- 07/27/22 Jefferies
- Alphabet price target lowered to $130 from $155 at Jefferies
- 07/25/22 TD Cowen
- Twitter price target lowered to $22 from $38 at Cowen
- 08/09/22 Wells Fargo
- Global Blood Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
- 08/08/22 Cantor Fitzgerald
- Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald
- 08/08/22 Oppenheimer
- Global Blood Therapeutics downgraded to Perform from Outperform at Oppenheimer
- 08/08/22 Stifel
- Global Blood Therapeutics downgraded to Hold from Buy at Stifel
- 08/08/22 RBC Capital
- Global Blood downgraded to Sector Perform from Outperform at RBC Capital
- 08/08/22 TD Cowen
- Global Blood Therapeutics downgraded to Market Perform from Outperform at Cowen
- $177.97 /
-11.97 (-6.30%) - 08/09/22 Mizuho
- Nvidia price target lowered to $250 from $290 at Mizuho
- 08/08/22 Summit Insights
- Nvidia underestimated its exposure to crypto mining, says Summit Insights
- 08/08/22 Oppenheimer
- Nvidia price target lowered to $250 from $300 at Oppenheimer
- 08/08/22 Truist
- Nvidia price target lowered to $216 from $283 at Truist
- 07/29/22 Evercore ISI
- Carlyle Group upgraded to Outperform from In Line at Evercore ISI
- 07/13/22 Deutsche Bank
- Carlyle Group price target lowered to $56 from $64 at Deutsche Bank
- 06/08/22 JMP Securities
- Carlyle Group initiated with an Outperform at JMP Securities
- 05/19/22 Deutsche Bank
- Carlyle Group price target lowered to $64 from $68 at Deutsche Bank
- 08/08/22 Canaccord
- Tesla price target raised to $881 from $815 at Canaccord
- 08/03/22 Morgan Stanley
- Tesla exposed to both risk and opportunity of battery race, says Morgan Stanley
- 08/02/22 Citi
- Tesla price target raised to $424 from $375 at Citi
- 07/18/22 Mizuho
- Emerson Electric price target lowered to $85 from $100 at Mizuho
- 07/13/22 Deutsche Bank
- Emerson Electric price target lowered to $97 from $110 at Deutsche Bank
- 07/12/22 Wells Fargo
- Emerson Electric price target raised to $89 from $87 at Wells Fargo
- 07/08/22 Barclays
- Emerson Electric price target lowered to $80 from $87 at Barclays
- 08/08/22 JPMorgan
- First Solar upgraded to Overweight from Neutral at JPMorgan
- 08/08/22 Guggenheim
- First Solar upgraded to Buy at Guggenheim on confidence in passage of IRA act
- 08/08/22 Guggenheim
- First Solar upgraded to Buy from Neutral at Guggenheim
- 08/05/22 Argus
- First Solar price target raised to $123 from $104 at Argus
- 08/08/22 JPMorgan
- TPI Composites upgraded to Overweight from Neutral at JPMorgan
- 08/04/22 TD Cowen
- TPI Composites price target raised to $20 from $15 at Cowen
- 07/19/22 Piper Sandler
- TPI Composites price target lowered to $12 from $14 at Piper Sandler
- 05/06/22 Roth MKM
- TPI Composites upgraded to Buy from Neutral at Roth Capital
- 08/08/22 Pivotal Research
- Roku downgraded to Sell from Hold at Pivotal Research
- 08/03/22 Citi
- Roku price target lowered to $125 from $165 at Citi
- 08/01/22 Morgan Stanley
- Roku price target lowered to $55 from $80 at Morgan Stanley
- 07/29/22 BofA
- BofA double downgrades Roku with headwinds seen lasting 2-3 quarters
WBD Warner Bros. Discovery - 08/08/22 Barrington
- Warner Bros. Discovery downgraded to Market Perform from Outperform at Barrington
- 08/05/22 Wells Fargo
- Warner Bros. Discovery downgraded to Equal Weight at Wells Fargo
- 08/05/22 Barclays
- Warner Bros. Discovery price target lowered to $17 from $19 at Barclays
- 08/04/22 Credit Suisse
- Warner Bros. Discovery price target lowered to $43 from $52 at Credit Suisse
- 08/08/22 Craig-Hallum
- Western Digital price target lowered to $85 from $90 at Craig-Hallum
- 08/08/22 Deutsche Bank
- Western Digital price target lowered to $56 from $64 at Deutsche Bank
- 08/08/22 Benchmark
- Western Digital downgraded to Hold at Benchmark amid sharp inventory correction
- 08/08/22 Baird
- Western Digital price target lowered to $55 from $75 at Baird
- 08/09/22 Deutsche Bank
- Signify Health, CVS deal could be 'win-win,' says Deutsche Bank
- 08/08/22 BofA
- CVS deal for Signify would help with continued evolution, says BofA
- 08/04/22 Evercore ISI
- CVS Health removed from 'TAP Outperform' list at Evercore ISI
- 08/04/22 Deutsche Bank
- CVS Health price target raised to $120 from $113 at Deutsche Bank
- 08/03/22 Tigress Financial
- Alphabet price target raised to $186 from $183 at Tigress Financial
- 07/27/22 Truist
- Chrome cookie phase-out delay positive for Criteo, says Truist
- 07/27/22 KeyBanc
- Google's cookie phase-out delay not surprising, says KeyBanc
- 07/27/22 RBC Capital
- Google cookie phase-out delay adds another year of uncertainty, says RBC Capital
- 06/14/22 Morgan Stanley
- Sonos downgraded to Equal Weight at Morgan Stanley amid inflation pressures
- 06/14/22 Morgan Stanley
- Sonos downgraded to Equal Weight from Overweight at Morgan Stanley
- 05/31/22 Jefferies
- Sonos price target lowered to $35 from $45 at Jefferies
- 05/12/22 DA Davidson
- Sonos price target lowered to $40 from $49 at DA Davidson
- $22.06 /
+2.195 (+11.05%) - 08/08/22 TD Cowen
- Signify Health price target raised to $24 from $14 at Cowen
- 08/04/22 Piper Sandler
- Signify Health price target raised to $34 from $32 at Piper Sandler
- 08/01/22 Morgan Stanley
- Morgan Stanley says Boeing approval to resume 787 deliveries a positive catalyst
- 08/01/22 Goldman Sachs
- Boeing 787 resumption would clear 'significant overhang,' says Goldman Sachs
- 08/01/22 Citi
- Boeing news removes $33 per share of downside risk, says Citi
- 07/28/22 JPMorgan
- Boeing price target raised to $200 from $188 at JPMorgan
- 08/08/22 B. Riley
- B. Riley thinks Globalstar's mystery satellite capacity customer is Apple
- 08/05/22 DA Davidson
- Amazon may be be more willing to do M&A under Jassy, says DA Davidson
- 07/29/22 UBS
- Amazon.com price target raised to $180 from $167 at UBS
- 07/29/22 BofA
- Amazon price target bumped to $170 at BofA after 'mostly positive' quarter
- $241.52 /
+101.41 (+72.38%) - 08/09/22 Mizuho
- Karuna Therapeutics price target raised to $276 from $190 at Mizuho
- 08/09/22 Citi
- Zai Lab price target raised to $199 from $193 at Citi
- 08/09/22 BofA
- Karuna Therapeutics price target raised to $261 from $160 at BofA
- 08/08/22 Stifel
- Cerevel Therapeutics price target raised to $54 from $50 at Stifel
- $34.96 /
+11.46 (+48.77%) - 08/08/22 Oppenheimer
- CinCor Pharma price target raised to $60 from $35 at Oppenheimer
- 07/21/22 Oppenheimer
- CinCor Pharma price target raised to $35 from $30 at Oppenheimer
- 02/01/22 Oppenheimer
- CinCor Pharma initiated with an Outperform at Oppenheimer
- 02/01/22 Evercore ISI
- CinCor Pharma initiated with an Outperform at Evercore ISI
- 07/27/22 Stifel
- Stifel keeps Buy on W&T Offshore, raises price target to $8.40
- 10/20/21 Stifel
- W&T Offshore upgraded to Buy at Stifel on improving prices
- 10/20/21 Stifel
- W&T Offshore upgraded to Buy from Hold at Stifel
- 09/09/21 Roth MKM
- W&T Offshore should be bought on any weakness, says Roth Capital
- 08/09/22 Wells Fargo
- uniQure price target lowered to $24 from $34 at Wells Fargo
- 08/09/22 H.C. Wainwright
- uniQure selloff brings attractive entry point, says H.C. Wainwright
- 08/08/22 Chardan
- uniQure price target lowered to $60 from $65 at Chardan
- 08/08/22 Truist
- uniQure's high-dose HD data still on track for 1H23, says Truist
RETA Reata Pharmaceuticals - $24.02 /
-11.895 (-33.12%) - 08/09/22 Baird
- Reata Pharmaceuticals price target lowered to $27 from $37 at Baird
- 08/08/22 Goldman Sachs
- Reata sinks on Friedreich's ataxia update but Goldman remains positive
- 08/08/22 Goldman Sachs
- Reata Pharmaceuticals price target raised to $76 from $73 at Goldman Sachs
- 05/27/22 Citi
- Reata Pharmaceuticals price target raised to $46 from $43 at Citi
- 08/09/22 Morgan Stanley
- Palantir price target lowered to $11 from $13 at Morgan Stanley
- 08/09/22 Citi
- Palantir price target lowered to $6 from $7 at Citi
- 08/09/22 Deutsche Bank
- Palantir downgraded to Sell from Hold at Deutsche Bank
- 08/08/22 Jefferies
- Palantir price target lowered to $12 from $13 at Jefferies
- 08/09/22 Stephens
- Tyson Foods price target lowered to $95 from $100 at Stephens
- 08/09/22 BMO Capital
- Tyson Foods price target lowered to $90 from $99 at BMO Capital
- 08/09/22 Barclays
- Tyson Foods price target lowered to $89 from $100 at Barclays
- 08/09/22 Piper Sandler
- Piper upgrades Tyson Foods to Neutral with risks priced in
- 07/13/22 SVB Securities
- BioNTech upgraded to Outperform from Market Perform at SVB Securities
- 07/11/22 H.C. Wainwright
- BioNTech price target lowered to $283 from $298 at H.C. Wainwright
- 07/06/22 Canaccord
- BioNTech assumed with a Buy at Canaccord
- 06/13/22 Morgan Stanley
- Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley
- 07/21/22 Goldman Sachs
- Elanco downgraded to Sell from Buy at Goldman Sachs
- 07/18/22 TD Cowen
- Cowen believes Global Pharma quarterly results will be strong
- 07/18/22 JPMorgan
- JPMorgan cuts Elanco target, Zoetis remains top animal health idea
- 07/11/22 Piper Sandler
- Elanco initiated with a Neutral at Piper Sandler
- 08/08/22 RBC Capital
- Stericycle price target lowered to $70 from $82 at RBC Capital
- 05/12/22 Berenberg
- Stericycle downgraded on inflationary environment at Berenberg
- 05/12/22 Berenberg
- Stericycle downgraded to Hold from Buy at Berenberg
- 04/29/22 Baird
- Stericycle price target lowered to $63 from $72 at Baird
- 08/08/22
- W&T Offshore reports Q2 adjusted EPS $1.32 vs. 1c last year
- 03/08/22
- W&T Offshore reports Q4 adjusted EPS 10c, consensus 3c
- 08/05/22
- Western Digital sees Q1 EPS 35c-65c, consensus $1.96
- 08/05/22
- Western Digital reports Q4 EPS $1.78, consensus $1.68
- 04/28/22
- Western Digital sees Q4 adjusted EPS $1.60-$1.90, consensus $1.69
- 04/28/22
- Western Digital reports Q3 adjusted EPS $1.65, consensus $1.42
WBD Warner Bros. Discovery - 08/04/22
- Warner Bros. Discovery cuts FY22 adjusted EBITDA view to $9.0B-$9.5B
- 08/04/22
- Warner Bros. Discovery reports Q2 EPS with items ($1.50), consensus (3c)
- 08/04/22
- Notable companies reporting after market close
- 04/26/22
- Warner Bros. Discovery reports Q1 diluted EPS 69c vs. 21c a year ago
- 07/22/22
- Twitter reports Q2 EPS (8c), consensus 14c
- 07/21/22
- Notable companies reporting before tomorrow's open
- 04/28/22
- Twitter withdrawing previously provided outlook given pending acquisition
- 08/08/22
- Tyson Foods sees 2022 revenue $52B-$54B, consensus $52.8B
- 08/08/22
- Tyson Foods reports Q3 adjusted EPS $1.94 vs. $2.70 last year
- 07/06/22
- Tyson Foods buys strategic stake in Tanmiah of Saudi Arabia
- 05/09/22
- Tyson Foods raises FY22 revenue view to $52B-$54B from $49B-$51B
- 07/20/22
- Tesla reports Q2 EPS $2.27, consensus $1.85
- 07/20/22
- Notable companies reporting after market close
- 04/20/22
- Tesla reports Q1 EPS $3.22, consensus $2.26
- 04/20/22
- Notable companies reporting after market close
- 08/03/22
- TPI Composites sees FY22 capital expenditures $15M-$20M down from $25M-$30M
- 08/03/22
- TPI Composites reports Q2 EPS (48c), consensus (41c)
- 05/05/22
- TPI Composites sees FY22 capital expenditures $25M-$30M
- 05/05/22
- TPI Composites reports Q1 EPS (71c), consensus (87c)
- 08/08/22
- Stericycle narrows FY22 EPS view to $2.00-$2.15 from $2.00-$2.30
- 08/05/22
- Stericycle reports Q2 adjusted EPS 48c vs 67c last year
- 04/28/22
- Stericycle reports Q1 adjusted EPS 32c, consensus 46c
- 02/24/22
- Stericycle sees FY22 adjusted EPS $2.00-$2.30, consensus $2.32
- 05/11/22
- Sonos backs FY22 revenue view $1.95B-$2B, consensus $1.97B
- 05/11/22
- Sonos reports Q2 adjusted EPS 26c, consensus 7c
- 02/09/22
- Sonos raises FY24 revenue view to $2.5B, up 13% CAGR from FY22 view
- 02/09/22
- Sonos sees FY22 revenue $1.95B-$2.0B, consensus $1.95B
- $22.06 /
+2.195 (+11.05%) - 08/03/22
- Signify Health reports Q2 EPS ($2.10), consensus 10c
- 05/04/22
- Signify Health reaffirms FY22 revenue view $948M-$971M, consensus $961.01M
- 05/04/22
- Signify Health reports Q1 EPS (6c), consensus 4c
- 03/02/22
- Signify Health sees FY22 revenue $948M-$971M, consensus $928.21M
- 07/28/22
- Roku sees Q3 revenue roughly $700M, consensus $901.73M
- 07/28/22
- Roku reports Q2 EPS (82c), consensus (68c)
- 04/28/22
- Roku backs FY22 revenue growth view of 35% y/y, consensus $3.72B
RETA Reata Pharmaceuticals - $24.02 /
-11.895 (-33.12%) - 08/08/22
- Reata Pharmaceuticals reports Q2 EPS ($2.02) , consensus ($2.02)
- 05/10/22
- Reata Pharmaceuticals reports Q1 adjusted EPS ($1.33), consensus ($2.15)
- 02/28/22
- Reata Pharmaceuticals reports Q4 EPS ($2.35), consensus ($2.31)
- 08/08/22
- uniQure reports Q2 EPS (84c) vs $8.51 last year
- 05/02/22
- uniQure reports Q1 EPS ($1.00), consensus (93c)
- 02/25/22
- uniQure reports 2021 EPS $7.04, consensus $6.20
- 08/08/22
- Palantir sees FY22 revenue $1.9B - $1.902B , consensus $1.96B
- 08/08/22
- Palantir sees Q3 revenue $474M - $475M , consensus $506.88M
- 08/08/22
- Palantir reports Q2 EPS (9c) vs. (7c) last year
- 05/09/22
- Palantir sees Q2 revenue base case $470M, consensus $483.84M
- 07/28/22
- Pfizer raises FY22 adjusted EPS view to $6.30-$6.45 from $6.25-$6.45
- 07/28/22
- Pfizer reports Q2 adjusted EPS $2.04, consensus $1.80
- 07/27/22
- Notable companies reporting before tomorrow's open
- $177.97 /
-11.97 (-6.30%) - 08/08/22
- Nvidia reports preliminary Q2 revenue $6.7B, consensus $8.1B
- 05/25/22
- Nvidia sees Q2 revenue $8.1B, +/- 2%, consensus $8.45B
- 05/25/22
- Nvidia reports Q1 EPS $1.36, consensus $1.29
- 05/25/22
- Notable companies reporting after market close
- $241.52 /
+101.41 (+72.38%) - 08/08/22
- Karuna Therapeutics reports Q2 EPS ($2.17), consensus ($2.09)
- 05/05/22
- Karuna Therapeutics reports Q1 EPS ($1.95), consensus ($2.11)
- 02/24/22
- Karuna Therapeutics reports Q4 EPS (94c), consensus ($1.73)
- 07/26/22
- Alphabet reports Q2 EPS $1.21, consensus $1.30
- 07/26/22
- Notable companies reporting after market close
- 04/26/22
- Alphabet reports Q1 EPS $24.62, consensus $25.96
- 04/26/22
- Notable companies reporting after market close
- 08/08/22
- Notable companies reporting after market close
- 05/04/22
- Global Blood Therapeutics reports Q1 EPS ($1.26), consensus ($1.30)
- 02/24/22
- Global Blood Therapeutics reports Q4 EPS ($1.36), consensus ($1.13)
- 07/28/22
- First Solar lowers FY22 EPS guidance to (25c)-25c from 0c-60c, consensus (4c)
- 07/28/22
- First Solar reports Q2 EPS 52c, consensus 23c
- 07/28/22
- Notable companies reporting after market close
- 04/28/22
- First Solar backs FY22 revenue view $2.4B-$2.6B, consensus $2.54B
- 05/04/22
- Emerson Electric sees Q3 adjusted EPS $1.25-$1.30, consensus $1.33
- 05/04/22
- Emerson Electric raises FY22 adjusted EPS view to $4.95-$5.10 from $4.90-$5.05
- 05/04/22
- Emerson Electric reports Q2 adjusted EPS $1.29, consensus $1.18
- 08/08/22
- Elanco sees Q3 adjusted EPS 12c-18c, consensus 26c
- 08/08/22
- Elanco lowers 2022 adjusted EPS view to $1.06-$1.13 from $1.15-$1.21
- 08/08/22
- Elanco reports Q2 adjusted EPS 36c, consensus 25c
- 05/09/22
- Elanco cuts FY22 adjusted EPS view to $1.15-$1.21 from $1.18-$1.24
- 08/03/22
- CVS Health raises FY22 revenue view to $307B-$312B from $305B-$310B
- 08/03/22
- CVS Health raises 2022 adjusted EPS view $8.40-$8.60 from $8.20-$8.40
- 08/03/22
- CVS Health reports Q2 adjusted EPS $2.40, consensus $2.17
- 08/02/22
- Notable companies reporting before tomorrow's open
- $34.96 /
+11.46 (+48.77%) - 08/08/22
- CinCor Pharma reports Q2 EPS (56c), consensus (50c)
- 05/10/22
- CinCor Pharma reports Q1 EPS (50c), consensus (50c)
- 03/22/22
- CinCor Pharma reports Q4 EPS ($15.71) vs. ($4.65) last year
- 04/29/22
- Carlyle Group reports Q1 EPS 74c vs. 58c last year
- 08/08/22
- BioNTech backs FY22 COVID-19 vaccine revenue view EUR 13B-EUR 17B
- 08/08/22
- BioNTech reports Q2 EPS EUR 6.45 vs. EUR 10.77 last year
- 05/09/22
- BioNTech reports Q1 EPS EUR 14.24 vs. EUR 4.39 last year
- 03/30/22
- BioNTech reports Q4 EPS EUR 12.18 vs. EUR 1.43 last year
- 07/27/22
- Boeing reports Q2 core EPS (37c), consensus (16c)
- 07/26/22
- Notable companies reporting before tomorrow's open
- 04/27/22
- Boeing reports Q1 core EPS ($2.75), consensus (12c)
- 07/28/22
- Amazon reports Q2 AWS net sales $19.73B vs. $14.81B a year ago
- 07/28/22
- Amazon sees Q3 revenue $125B-$130B, consensus $126.42B
- 07/28/22
- Amazon reports Q2 EPS (20c) with Rivian loss, consensus 13c
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 08/08/22
- W&T Offshore rises 18.5%
- 08/08/22
- W&T Offshore sees 2022 total equivalents 14,450-15,450 MBoe
- 08/08/22
- W&T Offshore sees Q3 total equivalents 3,550-4,050 MBoe
- 08/08/22
- W&T Offshore sees 2022 average daily equivalents 39.5-42 MBoe/d
- 07/26/22
- Winnebago appoints Casey Tubman as Newmar president
- 08/05/22
- Western Digital drops 8% to $45.80 after Q1 guidance misses estimates
- 07/21/22
- Western Digital, Micron trade lower after Seagate earnings miss
- 07/21/22
- Seagate drops 11% to $74.05 after results miss estimates
- 06/08/22
- Western Digital jumps 3.7% after announcing review to split Flash and HDD units
WBD Warner Bros. Discovery - 08/04/22
- Warner Bros. Discovery backs long-term leverage target of 2.5-3.0
- 08/04/22
- Warner Bros. Discovery sees FY23 adjusted EBITDA of 'at least $12B'
- 08/04/22
- AT&T, Warner Bros. Discovery announces distribution pact for HBO Max
- 08/04/22
- Warner Bros. Discovery launches dedicated CNN Originals hub on discovery+
- 08/05/22
- Twitter rejects Elon Musk's claims that he was 'hoodwinked'
- 08/05/22
- Twitter Chairman says Musk's claims 'factually inaccurate'
- 08/08/22
- Tyson Foods: Demand for chicken 'extremely strong'
- 08/08/22
- Tyson: Prepared fods unit can't fulfill all orders due to supply constraints
- 08/08/22
- Tyson Foods CEO says demand 'relatively steady'
- 08/08/22
- Tyson Foods focused on overcoming supply chain challenges, says CEO
- $905.20 /
+40.72 (+4.71%) - 08/07/22
- Elon Musk challenges Twitter CEO to 'a public debate' on bots
- 08/07/22
- Musk says Twitter deal should not proceed if SEC filings 'materially false'
- 08/05/22
- Tesla confirms three-for-one stock split
- 08/03/22
- American Battery Metals appoints Belanger as Staff Analytical Chemist
- 05/23/22
- TPI Composites appoints Miller as CFO
- 05/19/22
- TPI Composites approves changes to corporate governance policies
- 02/25/22
- TPI Composites trading resumes
- 02/25/22
- TPI Composites trading halted, volatility trading pause
- 04/20/22
- Stericycle confirms anti-corruption resolutions with DOJ, SEC
- 04/20/22
- Stericycle charged by SEC with bribery schemes in Latin America
- 02/24/22
- Stericycle sees five-year CAGR of 3%-5%
- 05/16/22
- David Einhorn's Greenlight adds Southwestern, exits Sonos in Q1
- 05/11/22
- Sonos introduces Sonos Voice Control
- 04/11/22
- Sonos acquiures 'audio transducers' firm Mayht for $100M to enhance portfolio
- 03/30/22
- Sonos to replace Chart Industries in S&P 600 at open on 3/30
- $22.80 /
+2.935 (+14.77%) - 08/08/22
- Signify Health rises 14.5%
- 08/08/22
- Signify Health rises 15.9%
- 08/03/22
- Signify Health sees FY HCS revenue $800M-$810M
- 08/03/22
- Paramount+ to launch as a Premium Subscription within Roku Channel
- 07/28/22
- Roku drops 25% to $63.40 after Q2 results, Q3 guidance miss estimates
- 07/26/22
- Cathie Wood's ARK Investment bought 585K shares of Roku today
- 06/23/22
- Crackle launches updated app on Roku devices
RETA Reata Pharmaceuticals - $24.10 /
-11.815 (-32.90%) - 08/08/22
- Reata Pharmaceuticals trading resumes
- 08/08/22
- Reata Pharmaceuticals trading halted, volatility trading pause
- 05/26/22
- Reata Pharmaceuticals' NDA for omaveloxolone granted Priority Review by FDA
- 03/31/22
- Reata Pharmaceuticals completes rolling submission for omaveloxolone NDA
- 06/23/22
- uniQure provides update on low-dose cohort in Phase I/II trial of AMT-130
- 06/22/22
- uniQure announces grant equity awards to 32 new employees
- 05/24/22
- uniQure announces FDA accepts priority review BLA for etranacogene dezaparvovec
- 05/11/22
- uniQure announces inducement grants under Nasdaq listing rule 5635(c)(4)
- $10.12 /
-1.325 (-11.58%) - 08/08/22
- Palantir falls -12.0%
- 08/08/22
- Palantir falls -14.4%
- 08/08/22
- Palantir falls -12.2%
- 07/28/22
- Palantir announces $99.9M contract with U.S. Army Research Laboratory
- 08/07/22
- Myovant Sciences, Pfizer receive FDA approval of MYFEMBREE
- $173.92 /
-16.02 (-8.43%) - 08/08/22
- Nvidia falls 6.9% to $176.74 after negative Q2 revenue pre-announcement
- 07/20/22
- Motorsport Games brings two titles to NVIDIA GeForce NOWNvidia
- 07/15/22
- U.S. video game spending falls 11% y/y in June, says NPD
- 07/12/22
- Nvidia announces hybrid quantum-classical computing platform
- $235.28 /
+95.17 (+67.93%) - 08/08/22
- Zai Lab partner Karuna announces results from Phase 3 EMERGENT-2 trial
- 08/08/22
- Karuna Therapeutics says Phase 3 EMERGENT-2 trial met primary endpoint
- 07/28/22
- Google updates Play Store policies around intrusive advertisements
- 08/02/22
- Mandiant to not provide guidance due to pending transaction with Google
- 08/02/22
- Thryv and Google team to streamline communication for small businesses
- 07/31/22
- Fly Intel: Top five weekend stock stories
- 07/29/22
- Google says Stadia game streaming service not shutting down
- 08/08/22
- Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash
- 08/08/22
- Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash
- 08/05/22
- Global Blood Therapeutics trading resumes
- 08/05/22
- Fulcrum Therapeutics up 8% after WSJ says Pfizer in talks to buy Global Blood
- 07/28/22
- First Solar to supply 2.4 GW of PV solar modules to Intersect Power
- 07/26/22
- First Solar issues 2022 Sustainability Report
- 07/25/22
- First Solar announces Akuo placed order for 500MW of thin film PV solar modules
- 07/21/22
- First Solar to supply Solarvest Holdings with 93 MW for Malaysian projects
- 08/08/22
- Whirlpool confirms pact with Emerson Electric to acquire InSinkErator for $3B
- 08/08/22
- Emerson Electric to sell InSinkErator business to Whirlpool for $3B
- 08/08/22
- Emerson Electric to sell InSinkErator business to Whirlpool for $3B
- 07/27/22
- Emerson unit AspenTech to acquire Micromine, no terms
- 05/13/22
- Soros buys Lucid, exits GM in Q1
- 04/27/22
- Elanco secures exclusive U.S. license for Bovaer production
- 04/12/22
- Elanco unveils plans for global headquarters in Indianapolis
- 04/11/22
- Elanco, Ginkgo Bioworks launch BiomEdit, a microbiome innovation company
- 08/07/22
- Fly Intel: Top five weekend stock stories
- 08/04/22
- CDW appoints Carolyn Wiesenhahn as CPO
- 08/03/22
- CVS Health says liquidity, cash position 'remain excellent'
- 08/03/22
- CVS Health says posted strong results across all business segments in Q2
- 08/04/22
- Coinbase trading resumes
- 08/04/22
- Coinbase trading halted, volatility trading pause
- 08/04/22
- Coinbase jumps 34% to $108.46 after announcing partnership with BlackRock
- 08/04/22
- Coinbase selected by BlackRock for crypto trading access
- $35.98 /
+12.48 (+53.11%) - 08/08/22
- CinCor Pharma announces data for Phase 2 BrigHtn trial evaluating baxdrostat
- 08/08/22
- CinCor Pharma announces upcoming milestones
- 07/26/22
- CinCor Pharma announces last patient randomized in Phase 2 HALO trial
- 06/01/22
- CinCor Pharma doses first patient in Phase 2 figHTN-CKD trial
- 08/08/22
- Carlyle Group CEO Kewsong Lee to step down, Bill Conway to be interim CEO
- 07/12/22
- Madison Dearborn Partners to acquire majority stake in Unison from Carlyle
- 05/16/22
- Carlyle to acquire ManTech for $96 per share in $4.2B enterprise value deal
- 05/09/22
- White Mountains to sell NSM Insurance Group to Carlyle Group
- 08/08/22
- BioNTech backs FY22 CapEx view EUR 450M- EUR 550M
- 08/05/22
- BioNTech, Genmab expand immunotherapies collaboration
- 07/27/22
- BioNTech, Pfizer to study enhanced COVID-19 mRNA-based vaccine candidate
- 07/19/22
- Pfizer, BioNTech complete submission to EMA for Omicron BA.1 adapted vaccine
- 08/03/22
- Microsoft says Teams now optimized for Mac computers
- 07/28/22
- Apple says 'constantly surveilling' the market for potential acquisitions
- 07/28/22
- Apple expects Q4 revenue to accelerate y/y
- 07/28/22
- Apple says response to iPhone 13 'continues to be strong'
- 08/08/22 Truist
- Global Blood Therapeutics downgraded to Hold from Buy at Truist
- 08/08/22 Stifel
- Global Blood Therapeutics downgraded to Hold from Buy at Stifel
- 08/08/22 William Blair
- Global Blood Therapeutics downgraded to Market Perform from Outperform at William Blair
- 08/08/22 Jefferies
- Global Blood Therapeutics downgraded to Hold from Buy at Jefferies
- 08/08/22 Piper Sandler
- Global Blood takeover by Pfizer 'solid outcome,' says Piper Sandler
- 08/08/22 Wedbush
- Wedbush downgrades Biohaven to Neutral, sees Pfizer acquisition on track
- 08/08/22 Canaccord
- Canaccord upgraded Global Blood to Buy before Pfizer takeover news
- $173.92 /
-16.02 (-8.43%) - 08/08/22 Piper Sandler
- Piper not surprised by Nvidia's gaming decline, but surprised by size of miss
- 07/25/22 Barclays
- Nvidia price target lowered to $200 from $295 at Barclays
- 07/20/22 Deutsche Bank
- Nvidia price target lowered to $175 from $190 at Deutsche Bank
- 07/15/22 Goldman Sachs
- Nvidia price target lowered to $166 from $192 at Goldman Sachs
- 07/29/22 Evercore ISI
- Carlyle Group upgraded to Outperform from In Line at Evercore ISI
- 07/13/22 Deutsche Bank
- Carlyle Group price target lowered to $56 from $64 at Deutsche Bank
- 06/08/22 JMP Securities
- Carlyle Group initiated with an Outperform at JMP Securities
- 05/19/22 Deutsche Bank
- Carlyle Group price target lowered to $64 from $68 at Deutsche Bank
- $905.20 /
+40.72 (+4.71%) - 08/08/22 Canaccord
- Tesla price target raised to $881 from $815 at Canaccord
- 08/05/22 Susquehanna
- Susquehanna downgrades Twitter on 'uncertainty and disruption' from takeover
- 08/03/22 Morgan Stanley
- Tesla exposed to both risk and opportunity of battery race, says Morgan Stanley
- 08/02/22 Citi
- Tesla price target raised to $424 from $375 at Citi
- 08/05/22 Susquehanna
- Twitter downgraded to Neutral from Positive at Susquehanna
- 07/27/22 Jefferies
- Alphabet price target lowered to $130 from $155 at Jefferies
- 07/25/22 TD Cowen
- Twitter price target lowered to $22 from $38 at Cowen
- 07/18/22 Mizuho
- Emerson Electric price target lowered to $85 from $100 at Mizuho
- 07/13/22 Deutsche Bank
- Emerson Electric price target lowered to $97 from $110 at Deutsche Bank
- 07/12/22 Wells Fargo
- Emerson Electric price target raised to $89 from $87 at Wells Fargo
- 07/08/22 Barclays
- Emerson Electric price target lowered to $80 from $87 at Barclays
- 07/15/22 JPMorgan
- Whirlpool price target lowered to $191 from $227 at JPMorgan
- 04/20/22 JPMorgan
- Whirlpool price target lowered to $205 from $221 at JPMorgan
- 04/05/22 Credit Suisse
- Whirlpool initiated with a Neutral at Credit Suisse
- 03/30/22 JPMorgan
- Whirlpool price target lowered to $221 from $295 at JPMorgan
- 08/08/22 JPMorgan
- First Solar upgraded to Overweight from Neutral at JPMorgan
- 08/08/22 Guggenheim
- First Solar upgraded to Buy at Guggenheim on confidence in passage of IRA act
- 08/08/22 Guggenheim
- First Solar upgraded to Buy from Neutral at Guggenheim
- 08/05/22 Argus
- First Solar price target raised to $123 from $104 at Argus
- 08/08/22 JPMorgan
- TPI Composites upgraded to Overweight from Neutral at JPMorgan
- 08/04/22 TD Cowen
- TPI Composites price target raised to $20 from $15 at Cowen
- 07/19/22 Piper Sandler
- TPI Composites price target lowered to $12 from $14 at Piper Sandler
- 05/06/22 Roth MKM
- TPI Composites upgraded to Buy from Neutral at Roth Capital
- 08/08/22 Pivotal Research
- Roku downgraded to Sell from Hold at Pivotal Research
- 08/03/22 Citi
- Roku price target lowered to $125 from $165 at Citi
- 08/01/22 Morgan Stanley
- Roku price target lowered to $55 from $80 at Morgan Stanley
- 07/29/22 BofA
- BofA double downgrades Roku with headwinds seen lasting 2-3 quarters
WBD Warner Bros. Discovery - 08/08/22 Barrington
- Warner Bros. Discovery downgraded to Market Perform from Outperform at Barrington
- 08/05/22 Wells Fargo
- Warner Bros. Discovery downgraded to Equal Weight at Wells Fargo
- 08/05/22 Barclays
- Warner Bros. Discovery price target lowered to $17 from $19 at Barclays
- 08/04/22 Credit Suisse
- Warner Bros. Discovery price target lowered to $43 from $52 at Credit Suisse
- 08/08/22 Craig-Hallum
- Western Digital price target lowered to $85 from $90 at Craig-Hallum
- 08/08/22 Deutsche Bank
- Western Digital price target lowered to $56 from $64 at Deutsche Bank
- 08/08/22 Benchmark
- Western Digital downgraded to Hold at Benchmark amid sharp inventory correction
- 08/08/22 Baird
- Western Digital price target lowered to $55 from $75 at Baird
- 08/08/22 BofA
- CVS deal for Signify would help with continued evolution, says BofA
- 08/04/22 Evercore ISI
- CVS Health removed from 'TAP Outperform' list at Evercore ISI
- 08/04/22 Deutsche Bank
- CVS Health price target raised to $120 from $113 at Deutsche Bank
- 07/21/22 Stifel
- Logical to see Oak Street, Cano as 'in play' after 1Life deal, says Stifel
- $22.80 /
+2.935 (+14.77%) - 08/08/22 TD Cowen
- Signify Health price target raised to $24 from $14 at Cowen
- 08/04/22 Piper Sandler
- Signify Health price target raised to $34 from $32 at Piper Sandler
- 07/28/22 RBC Capital
- Signify Health initiated with a Sector Perform at RBC Capital
- 08/08/22 B. Riley
- B. Riley thinks Globalstar's mystery satellite capacity customer is Apple
- 08/05/22 BMO Capital
- Skyworks price target raised to $135 from $120 at BMO Capital
- 08/05/22 Needham
- Meta Platforms outlook made worse by Apple's AdTech platform, says Needham
- 08/03/22 Morgan Stanley
- Apple App Store growth decelerated in July, says Morgan Stanley
- 08/03/22 Tigress Financial
- Alphabet price target raised to $186 from $183 at Tigress Financial
- 07/27/22 Truist
- Chrome cookie phase-out delay positive for Criteo, says Truist
- 07/27/22 KeyBanc
- Google's cookie phase-out delay not surprising, says KeyBanc
- 07/27/22 RBC Capital
- Google cookie phase-out delay adds another year of uncertainty, says RBC Capital
- 06/14/22 Morgan Stanley
- Sonos downgraded to Equal Weight at Morgan Stanley amid inflation pressures
- 06/14/22 Morgan Stanley
- Sonos downgraded to Equal Weight from Overweight at Morgan Stanley
- 05/31/22 Jefferies
- Sonos price target lowered to $35 from $45 at Jefferies
- 05/12/22 DA Davidson
- Sonos price target lowered to $40 from $49 at DA Davidson
- 08/08/22 Daiwa
- Coinbase downgraded to Outperform from Buy at Daiwa
- 08/05/22 Citi
- Citi cuts Coinbase target but opens 'upside Catalyst Watch'
- 08/04/22 JMP Securities
- JMP 'encouraged' by Coinbase partnership with BlackRock's Aladdin
- 08/04/22 Mizuho
- Coinbase shares jumped 20% 'for no good reason,' says Mizuho
- $235.28 /
+95.17 (+67.93%) - 07/14/22 SVB Securities
- SVB starts 'late-stage story' Karuna with Outperform, $170 target
- 07/14/22 SVB Securities
- Karuna Therapeutics initiated with an Outperform at SVB Securities
- 06/28/22 JMP Securities
- Karuna Therapeutics price target raised to $190 from $175 at JMP Securities
- 04/27/22 Mizuho
- Karuna Therapeutics price target raised to $190 from $178 at Mizuho
- $35.98 /
+12.48 (+53.11%) - 07/21/22 Oppenheimer
- CinCor Pharma price target raised to $35 from $30 at Oppenheimer
- 02/01/22 Oppenheimer
- CinCor Pharma initiated with an Outperform at Oppenheimer
- 02/01/22 Evercore ISI
- CinCor Pharma initiated with an Outperform at Evercore ISI
- 02/01/22 Jefferies
- CinCor Pharma initiated with a Buy at Jefferies
- 07/27/22 Stifel
- Stifel keeps Buy on W&T Offshore, raises price target to $8.40
- 10/20/21 Stifel
- W&T Offshore upgraded to Buy at Stifel on improving prices
- 10/20/21 Stifel
- W&T Offshore upgraded to Buy from Hold at Stifel
- 09/09/21 Roth MKM
- W&T Offshore should be bought on any weakness, says Roth Capital
RETA Reata Pharmaceuticals - $24.10 /
-11.815 (-32.90%) - 05/27/22 Citi
- Reata Pharmaceuticals price target raised to $46 from $43 at Citi
- 05/11/22 Ladenburg
- Reata Pharmaceuticals price target lowered to $67 from $75 at Ladenburg
- 05/10/22 Goldman Sachs
- Goldman ups target for Reata to $93, remains confident in approval
- 03/28/22 Jefferies
- Reata drop on Amylyx docs an opportunity to accumulate shares, says Jefferies
- 08/08/22 Truist
- uniQure's high-dose HD data still on track for 1H23, says Truist
- 05/05/22 Stifel
- uniQure price target lowered to $37 from $66 at Stifel
- 04/13/22 Truist
- uniQure price target lowered to $51 from $90 at Truist
- 03/30/22 Chardan
- uniQure price target lowered to $65 from $95 at Chardan
- $10.12 /
-1.325 (-11.58%) - 08/03/22 RBC Capital
- U.S. federal spending tracker 'worrisome' for Palantir, says RBC Capital
- 07/22/22 Monness Crespi
- Monness downgrades Palantir, says recent rally may be unsustainable
- 07/22/22 Monness Crespi
- Palantir downgraded to Neutral from Buy at Monness Crespi
- 07/21/22 Raymond James
- Raymond James starts Palantir with Strong Buy, sees shares doubling
- 07/20/22 Cleveland Research
- Tyson Foods downgraded to Neutral from Buy at Cleveland Research
- 07/01/22 Piper Sandler
- Tyson Foods price target lowered to $79 from $85 at Piper Sandler
- 05/03/22 Piper Sandler
- Tyson Foods downgraded to Underweight from Neutral at Piper Sandler
- 03/14/22 BMO Capital
- Tyson Foods downgraded to Market Perform from Outperform at BMO Capital
- 07/13/22 SVB Securities
- BioNTech upgraded to Outperform from Market Perform at SVB Securities
- 07/11/22 H.C. Wainwright
- BioNTech price target lowered to $283 from $298 at H.C. Wainwright
- 07/06/22 Canaccord
- BioNTech assumed with a Buy at Canaccord
- 06/13/22 Morgan Stanley
- Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley
- 07/21/22 Goldman Sachs
- Elanco downgraded to Sell from Buy at Goldman Sachs
- 07/18/22 TD Cowen
- Cowen believes Global Pharma quarterly results will be strong
- 07/18/22 JPMorgan
- JPMorgan cuts Elanco target, Zoetis remains top animal health idea
- 07/11/22 Piper Sandler
- Elanco initiated with a Neutral at Piper Sandler
- 08/08/22 RBC Capital
- Stericycle price target lowered to $70 from $82 at RBC Capital
- 05/12/22 Berenberg
- Stericycle downgraded on inflationary environment at Berenberg
- 05/12/22 Berenberg
- Stericycle downgraded to Hold from Buy at Berenberg
- 04/29/22 Baird
- Stericycle price target lowered to $63 from $72 at Baird
- 08/08/22
- W&T Offshore reports Q2 adjusted EPS $1.32 vs. 1c last year
- 03/08/22
- W&T Offshore reports Q4 adjusted EPS 10c, consensus 3c
- 07/25/22
- Whirlpool reports Q2 revenue, ex-currency, $5.2B, consensus $5.23B
- 07/25/22
- Whirlpool cuts FY22 adjusted EPS view to $22.00-$24.00 from $24.00-$26.00
- 07/25/22
- Whirlpool cuts FY22 revenue growth view to (6%) from 2%-3%, consensus $21.84B
- 07/25/22
- Whirlpool cuts FY22 cash from operating activities view to $1.85B from $1.95B
- 08/05/22
- Western Digital sees Q1 EPS 35c-65c, consensus $1.96
- 08/05/22
- Western Digital reports Q4 EPS $1.78, consensus $1.68
- 04/28/22
- Western Digital sees Q4 adjusted EPS $1.60-$1.90, consensus $1.69
- 04/28/22
- Western Digital reports Q3 adjusted EPS $1.65, consensus $1.42
WBD Warner Bros. Discovery - 08/04/22
- Warner Bros. Discovery cuts FY22 adjusted EBITDA view to $9.0B-$9.5B
- 08/04/22
- Warner Bros. Discovery reports Q2 EPS with items ($1.50), consensus (3c)
- 08/04/22
- Notable companies reporting after market close
- 04/26/22
- Warner Bros. Discovery reports Q1 diluted EPS 69c vs. 21c a year ago
- 07/22/22
- Twitter reports Q2 EPS (8c), consensus 14c
- 07/21/22
- Notable companies reporting before tomorrow's open
- 04/28/22
- Twitter withdrawing previously provided outlook given pending acquisition
- 08/08/22
- Tyson Foods sees 2022 revenue $52B-$54B, consensus $52.8B
- 08/08/22
- Tyson Foods reports Q3 adjusted EPS $1.94 vs. $2.70 last year
- 07/06/22
- Tyson Foods buys strategic stake in Tanmiah of Saudi Arabia
- 05/09/22
- Tyson Foods raises FY22 revenue view to $52B-$54B from $49B-$51B
- $905.20 /
+40.72 (+4.71%) - 07/20/22
- Tesla reports Q2 EPS $2.27, consensus $1.85
- 07/20/22
- Notable companies reporting after market close
- 04/20/22
- Tesla reports Q1 EPS $3.22, consensus $2.26
- 04/20/22
- Notable companies reporting after market close
- 08/03/22
- TPI Composites sees FY22 capital expenditures $15M-$20M down from $25M-$30M
- 08/03/22
- TPI Composites reports Q2 EPS (48c), consensus (41c)
- 05/05/22
- TPI Composites sees FY22 capital expenditures $25M-$30M
- 05/05/22
- TPI Composites reports Q1 EPS (71c), consensus (87c)
- 08/08/22
- Stericycle narrows FY22 EPS view to $2.00-$2.15 from $2.00-$2.30
- 08/05/22
- Stericycle reports Q2 adjusted EPS 48c vs 67c last year
- 04/28/22
- Stericycle reports Q1 adjusted EPS 32c, consensus 46c
- 02/24/22
- Stericycle sees FY22 adjusted EPS $2.00-$2.30, consensus $2.32
- 05/11/22
- Sonos backs FY22 revenue view $1.95B-$2B, consensus $1.97B
- 05/11/22
- Sonos reports Q2 adjusted EPS 26c, consensus 7c
- 02/09/22
- Sonos raises FY24 revenue view to $2.5B, up 13% CAGR from FY22 view
- 02/09/22
- Sonos sees FY22 revenue $1.95B-$2.0B, consensus $1.95B
- $22.80 /
+2.935 (+14.77%) - 08/03/22
- Signify Health reports Q2 EPS ($2.10), consensus 10c
- 05/04/22
- Signify Health reaffirms FY22 revenue view $948M-$971M, consensus $961.01M
- 05/04/22
- Signify Health reports Q1 EPS (6c), consensus 4c
- 03/02/22
- Signify Health sees FY22 revenue $948M-$971M, consensus $928.21M
- 07/28/22
- Roku sees Q3 revenue roughly $700M, consensus $901.73M
- 07/28/22
- Roku reports Q2 EPS (82c), consensus (68c)
- 04/28/22
- Roku backs FY22 revenue growth view of 35% y/y, consensus $3.72B
RETA Reata Pharmaceuticals - $24.10 /
-11.815 (-32.90%) - 05/10/22
- Reata Pharmaceuticals reports Q1 adjusted EPS ($1.33), consensus ($2.15)
- 02/28/22
- Reata Pharmaceuticals reports Q4 EPS ($2.35), consensus ($2.31)
- 08/08/22
- uniQure reports Q2 EPS (84c) vs $8.51 last year
- 05/02/22
- uniQure reports Q1 EPS ($1.00), consensus (93c)
- 02/25/22
- uniQure reports 2021 EPS $7.04, consensus $6.20
- $10.12 /
-1.325 (-11.58%) - 08/08/22
- Palantir sees FY22 revenue $1.9B - $1.902B , consensus $1.96B
- 08/08/22
- Palantir sees Q3 revenue $474M - $475M , consensus $506.88M
- 08/08/22
- Palantir reports Q2 EPS (9c) vs. (7c) last year
- 05/09/22
- Palantir sees Q2 revenue base case $470M, consensus $483.84M
- 07/28/22
- Pfizer raises FY22 adjusted EPS view to $6.30-$6.45 from $6.25-$6.45
- 07/28/22
- Pfizer reports Q2 adjusted EPS $2.04, consensus $1.80
- 07/27/22
- Notable companies reporting before tomorrow's open
- $173.92 /
-16.02 (-8.43%) - 08/08/22
- Nvidia reports preliminary Q2 revenue $6.7B, consensus $8.1B
- 05/25/22
- Nvidia sees Q2 revenue $8.1B, +/- 2%, consensus $8.45B
- 05/25/22
- Nvidia reports Q1 EPS $1.36, consensus $1.29
- 05/25/22
- Notable companies reporting after market close
- $235.28 /
+95.17 (+67.93%) - 08/08/22
- Karuna Therapeutics reports Q2 EPS ($2.17), consensus ($2.09)
- 05/05/22
- Karuna Therapeutics reports Q1 EPS ($1.95), consensus ($2.11)
- 02/24/22
- Karuna Therapeutics reports Q4 EPS (94c), consensus ($1.73)
- 07/26/22
- Alphabet reports Q2 EPS $1.21, consensus $1.30
- 07/26/22
- Notable companies reporting after market close
- 04/26/22
- Alphabet reports Q1 EPS $24.62, consensus $25.96
- 04/26/22
- Notable companies reporting after market close
- 05/04/22
- Global Blood Therapeutics reports Q1 EPS ($1.26), consensus ($1.30)
- 02/24/22
- Global Blood Therapeutics reports Q4 EPS ($1.36), consensus ($1.13)
- 07/28/22
- First Solar lowers FY22 EPS guidance to (25c)-25c from 0c-60c, consensus (4c)
- 07/28/22
- First Solar reports Q2 EPS 52c, consensus 23c
- 07/28/22
- Notable companies reporting after market close
- 04/28/22
- First Solar backs FY22 revenue view $2.4B-$2.6B, consensus $2.54B
- 05/04/22
- Emerson Electric sees Q3 adjusted EPS $1.25-$1.30, consensus $1.33
- 05/04/22
- Emerson Electric raises FY22 adjusted EPS view to $4.95-$5.10 from $4.90-$5.05
- 05/04/22
- Emerson Electric reports Q2 adjusted EPS $1.29, consensus $1.18
- 08/08/22
- Elanco sees Q3 adjusted EPS 12c-18c, consensus 26c
- 08/08/22
- Elanco lowers 2022 adjusted EPS view to $1.06-$1.13 from $1.15-$1.21
- 08/08/22
- Elanco reports Q2 adjusted EPS 36c, consensus 25c
- 05/09/22
- Elanco cuts FY22 adjusted EPS view to $1.15-$1.21 from $1.18-$1.24
- 08/03/22
- CVS Health raises FY22 revenue view to $307B-$312B from $305B-$310B
- 08/03/22
- CVS Health raises 2022 adjusted EPS view $8.40-$8.60 from $8.20-$8.40
- 08/03/22
- CVS Health reports Q2 adjusted EPS $2.40, consensus $2.17
- 08/02/22
- Notable companies reporting before tomorrow's open
- 05/10/22
- Coinbase reports Q1 EPS ($1.98) vs. $3.80 last year
- 05/10/22
- Coinbase reports Q1 revenue $1.165B, consensus $1.48B
- 05/10/22
- Notable companies reporting after market close
- 02/24/22
- Coinbase reports Q4 adjusted EBITDA $1.21B vs. $288M y/y
- $35.98 /
+12.48 (+53.11%) - 08/08/22
- CinCor Pharma reports Q2 EPS (56c), consensus (50c)
- 05/10/22
- CinCor Pharma reports Q1 EPS (50c), consensus (50c)
- 03/22/22
- CinCor Pharma reports Q4 EPS ($15.71) vs. ($4.65) last year
- 04/29/22
- Carlyle Group reports Q1 EPS 74c vs. 58c last year
- 08/08/22
- BioNTech backs FY22 COVID-19 vaccine revenue view EUR 13B-EUR 17B
- 08/08/22
- BioNTech reports Q2 EPS EUR 6.45 vs. EUR 10.77 last year
- 05/09/22
- BioNTech reports Q1 EPS EUR 14.24 vs. EUR 4.39 last year
- 03/30/22
- BioNTech reports Q4 EPS EUR 12.18 vs. EUR 1.43 last year
- 07/28/22
- Apple reports Q3 EPS $1.20, consensus $1.16
- 04/28/22
- Apple says y/y Q3 revenue growth to be impacted by COVID
- 04/28/22
- Apple reports Q2 EPS $1.52, consensus $1.43
|
Recommendations
|
RBC Capital analyst Sean… RBC Capital analyst Sean Dodge lowered the firm's price target on Stericycle to $70 from $82 but keeps an Outperform rating on the shares after its Q2 earnings and guidance. The management reduced its EPS outlook on Friday, but with consensus already at the low-end of the previous ranges, this is a better outcome than what was being anticipated, the analyst tells investors in a research note. Stericycle is still one of his "highest conviction picks for the year", Dodge adds. ShowHide Related Items >><< - 04/20/22
- Stericycle confirms anti-corruption resolutions with DOJ, SEC
- 04/20/22
- Stericycle charged by SEC with bribery schemes in Latin America
- 02/24/22
- Stericycle sees five-year CAGR of 3%-5%
- 05/12/22 Berenberg
- Stericycle downgraded on inflationary environment at Berenberg
- 05/12/22 Berenberg
- Stericycle downgraded to Hold from Buy at Berenberg
- 04/29/22 Baird
- Stericycle price target lowered to $63 from $72 at Baird
- 03/23/22 RBC Capital
- Stericycle named 'New Top Idea' at RBC Capital
- 08/08/22
- Stericycle narrows FY22 EPS view to $2.00-$2.15 from $2.00-$2.30
- 08/05/22
- Stericycle reports Q2 adjusted EPS 48c vs 67c last year
- 04/28/22
- Stericycle reports Q1 adjusted EPS 32c, consensus 46c
- 02/24/22
- Stericycle sees FY22 adjusted EPS $2.00-$2.30, consensus $2.32
|